Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application

被引：35

作者：

Wei, Ran ^{[1
,2
]}

Dean, Dylan C. ^{[1
]}

Thanindratarn, Pichaya ^{[1
]}

Hornicek, Francis J. ^{[1
]}

Guo, Wei ^{[2
]}

Duan, Zhenfeng ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Dept Orthoped Surg, Sarcoma Biol Lab, David Geffen Sch Med, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA

[2] Peking Univ Peoples Hosp, Musculoskeletal Tumor Ctr, 11 Xizhimen South St, Beijing 100044, Peoples R China

来源：

CANCER LETTERS | 2020年 / 479卷

基金：

美国国家卫生研究院;

关键词：

Cancer testis antigen; Sarcoma; Expression; Function; Immunotherapy; T-CELL RESPONSES; TUMOR-ASSOCIATED ANTIGEN; CANCER/TESTIS ANTIGENS; PROGNOSTIC RELEVANCE; NY-ESO-1; EXPRESSION; SYNOVIAL SARCOMA; GENE-EXPRESSION; NORMAL-TISSUES; MAGE-A; MELANOMA;

D O I：

10.1016/j.canlet.2019.10.024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sarcomas are a group of heterogeneous malignancies of mesenchymal origin. Patient outcomes remain especially grim for those with recurrent or metastatic disease, and current therapeutic strategies have not significantly improved outcomes over the past few decades. This has led to a number of studies assessing novel therapies. Cancer testis antigens (CTAs) are tumor-associated antigens with physiologic expression in the testis and various malignancies, including sarcomas. Genes encoding CTAs include MAGE, NY-ESO-1, PRAME, TRAG-3/CSAGE, and SSX. The importance and function of CTAs in tumorigenesis have gained recognition in recent years. They are also proving as robust diagnostic and prognostic biomarkers. Therapeutically, antigens derived from CTAs are highly recognizable by T lymphocytes and therefore capable of generating a potent antitumor immune response. CTAs are, therefore, promising targets for novel immunotherapies. Here we review the emerging works on expression, function, and immunotherapeutic application of CTAs in sarcoma therapy.

引用

页码：54 / 60

页数：7

共 97 条

[11] Insights on PRAME and osteosarcoma by means of gene expression profiling [J].

Caminada Toledo, Silvia Regina ;

Zago, Marco Antonio ;

Oliveira, Indhira Dias ;

Proto-Siqueira, Rodrigo ;

Okamoto, Oswaldo K. ;

Severino, Patricia ;

Vencio, Ricardo Z. N. ;

Gamba, Francine Tesser ;

Silva, Wilson A. ;

Moreira-Filho, Carlos A. ;

Dalla Torre, Cristiane A. ;

Seixas Alves, Maria Tereza ;

Garcia-Filho, Reynaldo J. ;

Simpson, Andrew J. G. ;

Petrilli, Antonio Sergio .

JOURNAL OF ORTHOPAEDIC SCIENCE, 2011, 16 (04) :458-466

[12]

Chawla S., 2017, EUR SOC MED ONC ESMO

[13] Expression and Therapeutic Potential of SOX9 in Chordoma [J].

Chen, Hua ;

Garbutt, Cassandra C. ;

Spentzos, Dimitrios ;

Choy, Edwin ;

Hornicek, Francis J. ;

Duan, Zhenfeng .

CLINICAL CANCER RESEARCH, 2017, 23 (17) :5176-5186

[14] A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening [J].

Chen, YT ;

Scanlan, MJ ;

Sahin, U ;

Tureci, O ;

Gure, AO ;

Tsang, SL ;

Williamson, B ;

Stockert, E ;

Pfreundschuh, M ;

Old, LJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1914-1918

[15]

Chomez P, 2001, CANCER RES, V61, P5544

[16] Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide [J].

Coral, Sandra ;

Parisi, Giulia ;

Nicolay, Hugues J. M. G. ;

Colizzi, Francesca ;

Danielli, Riccardo ;

Fratta, Elisabetta ;

Covre, Alessia ;

Taverna, Pietro ;

Sigalotti, Luca ;

Maio, Michele .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) :605-614

[17] Cancer/testis antigen expression in human mesenchymal stem cells:: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression [J].

Cronwright, G ;

Le Blanc, K ;

Götherström, C ;

Darcy, P ;

Ehnman, M ;

Brodin, B .

CANCER RESEARCH, 2005, 65 (06) :2207-2215

[18] Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259 T Cells in Synovial Sarcoma [J].

D'Angelo, Sandra P. ;

Melchiori, Luca ;

Merchant, Melinda S. ;

Bernstein, Donna ;

Glod, John ;

Kaplan, Rosandra ;

Grupp, Stephan ;

Tap, William D. ;

Chagin, Karen ;

Binder, Gwendolyn K. ;

Basu, Samik ;

Lowther, Daniel E. ;

Wang, Ruoxi ;

Bath, Natalie ;

Tipping, Alex ;

Betts, Gareth ;

Ramachandran, Indu ;

Navenot, Jean-Marc ;

Zhang, Hua ;

Wells, Daniel K. ;

Van Winkle, Erin ;

Kari, Gabor ;

Trivedi, Trupti ;

Holdich, Tom ;

Pandite, Lini ;

Amado, Rafael ;

Mackall, Crystal L. .

CANCER DISCOVERY, 2018, 8 (08) :944-957

[19] Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells [J].

D'Arcy, Padraig ;

Maruwge, Wessen ;

Wolahan, Barry ;

Ma, Limin ;

Brodin, Bertha .

PLOS ONE, 2014, 9 (04)

[20] MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial [J].

Dreno, Brigitte ;

Thompson, John F. ;

Smithers, Bernard Mark ;

Santinami, Mario ;

Jouary, Thomas ;

Gutzmer, Ralf ;

Levchenko, Evgeny ;

Rutkowski, Piotr ;

Grob, Jean-Jacques ;

Korovin, Sergii ;

Drucis, Kamil ;

Grange, Florent ;

Machet, Laurent ;

Hersey, Peter ;

Krajsova, Ivana ;

Testori, Alessandro ;

Conry, Robert ;

Guillot, Bernard ;

Kruit, Wim H. J. ;

Demidov, Lev ;

Thompson, John A. ;

Bondarenko, Igor ;

Jaroszek, Jaroslaw ;

Puig, Susana ;

Cinat, Gabriela ;

Hauschild, Axel ;

Goeman, Jelle J. ;

van Houwelingen, Hans C. ;

Ulloa-Montoya, Fernando ;

Callegaro, Andrea ;

Dizier, Benjamin ;

Spiessens, Bart ;

Debois, Muriel ;

Brichard, Vincent G. ;

Louahed, Jamila ;

Therasse, Patrick ;

Debruyne, Channa ;

Kirkwood, John M. .

LANCET ONCOLOGY, 2018, 19 (07) :916-929

← 1 2 3 4 5 6 7 8 9 10 →